MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with T

Terbinafine

Terbinafine 250mg tablets

Use with caution

Stability notes for Terbinafine 250mg tablets

Protect from light.

Provenance

This compatibility recommendation is derived from Lamisil 250mg tablets (Novartis Pharmaceuticals UK Ltd).

Suppliers (16) of Terbinafine 250mg tablets
Terbinafine 250mg tablets (A A H Pharmaceuticals Ltd)
Terbinafine 250mg tablets (Accord-UK Ltd)
Terbinafine 250mg tablets (Alliance Healthcare (Distribution) Ltd)
Terbinafine 250mg tablets (Almus Pharmaceuticals Ltd)
Terbinafine 250mg tablets (Crescent Pharma Ltd)
Terbinafine 250mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Terbinafine 250mg tablets (Drugsrus Ltd)
Terbinafine 250mg tablets (Key Pharmaceuticals Ltd)
Terbinafine 250mg tablets (Medihealth (Northern) Ltd)
Terbinafine 250mg tablets (Medreich Plc)
Terbinafine 250mg tablets (Milpharm Ltd)
Terbinafine 250mg tablets (Noumed Life Sciences Ltd)
Terbinafine 250mg tablets (Phoenix Healthcare Distribution Ltd)
Terbinafine 250mg tablets (Sigma Pharmaceuticals Plc)
Terbinafine 250mg tablets (Somex Pharma)
Terbinafine 250mg tablets (Torrent Pharma (UK) Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.